How injectable opioid agonist treatment (iOAT) care could be improved? service providers and stakeholders’ perspectives

Original research
par
Magel, Tianna et al

Date de publication

2023

Géographie

Canada

Langue de la ressource

English

Texte disponible en version intégrale

Non

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

This study aimed to understand stakeholder and provider perspectives on injectable opioid agonist treatment (iOAT) care and how it can be improved to better meet service users’ needs.

Constatations/points à retenir

Stakeholder narratives highlight the importance they attribute to client autonomy, individualized care, tensions between providers and the system (policies, governing structures, etc., that establish, facilitate and determine how iOAT is delivered in Canada) as well as power dynamics between providers and service users.

La conception ou méthodologie de recherche

Semi-structured interviews (n = 11), email correspondence (n = 2), a focus group (n = 4), and one regional meeting were conducted with iOAT stakeholders to receive feedback on how iOAT can better meet service users’ needs

Mots clés

About prescribers
About PWUD
Substitution/OAT